Analysis
Latest NK PRO analysis related to the DPRK
North Korea is sending mixed signals about the state of its market reforms
North Korea hinted that it was going to exert more state control over the economy, but is that really happening?
March 29, 2021
Despite rising tensions, North and South Korea will likely talk again
For all its missile tests and state media condemnations, Pyongyang may still want to talk to Seoul in the coming years
March 26, 2021
North Korea wants Biden’s attention. The best way to get it: ballistic missiles.
Kim Jong Un fired two short-range ballistic missiles to get on the U.S.’ agenda before a key policy review is finished
March 25, 2021
North Korea’s cruise missile launch is serious — not just ‘business as usual’
Washington's reaction was understandable, but DPRK cruise missiles may soon become delivery systems for nuclear weapons
March 25, 2021
Why Moon Jae-in can’t be pressured into tackling North Korean human rights
President Moon Jae-in failed to implement parts of a North Korean human rights act and continues to rebuff the topic
March 24, 2021
Moon’s desperate North Korea outreach is costing him credibility in Washington
Moon must prove that he’s a rational actor — not an ideologue hell-bent on inter-Korean dialogue
March 23, 2021
Seoul needs to budge on big issues if it wants Tokyo’s help on North Korea
South Korea wants to mend ties with Japan to please the U.S., but appears inflexible on controversial historical issues
March 22, 2021
Kim and Moon are the biggest losers of Blinken’s Asia visit
The Biden administration is not offering Pyongyang the flexibility that both North and South Korea likely hoped for
March 19, 2021
North Korea’s new China ambassador may boost economic cooperation to new heights
Diplomat Ri Ryong Nam was appointed around the same time as a series of reports on increased China-DPRK cooperation
March 18, 2021
China’s new domestic vaccine mandate could devastate future North Korea travel
Beijing announced that visa applicants will have to be inoculated with a Chinese-made vaccine
March 18, 2021
